- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 15.9M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $111.72M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $119.45M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.69B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.72B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.88B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.89B |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 16.14M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $2.65M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $162.35M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $159.25M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.26 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.27 |
| Net Income | Q1 2025 · Mar 31, 2024 | $4.28M |